Kazia Therapeutics Annual Reports 2023

86 FINANCIAL REPORT SHAREHOLDER INFORMATION CONTINUED Substantial holders Substantial holders of equity in the Compay, as notified to the ASX by that holder, are: Name Number % BNY Mellon 82,578,886 36.21% Willoughby Capital Pty Ltd <Willoughby Capital A/C> and Associates 30,112,339 15.95% Platinum Investment Management Limited 23,083,022 9.77% Voting rights Quoted equity securities The voting rights attached to fully paid ordinary shares are that on a show of hands, every member present at a meeting in person or who has cast a Direct Vote will have one vote. On a poll, every member present or who has cast a Direct Vote will have one vote foreach fully paid share. Unquoted equity securities There are no voting rights attached to options. Options will rank equally with the company’s fully paid ordinary shares if and when the options vest and are thereafter exercised (prior to the applicable expiry date).

RkJQdWJsaXNoZXIy MjE2NDg3